CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement
- 4 Option exercise Director acquired 4,000 shares (option exercise)
- 4 Planned sale Chief Commercial Officer sold 910 shares at an average $493.78 ($449,339)
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 1,577 shares at $492.42 ($776,546)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 647 shares at $492.42 ($318,596)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale General Counsel sold 692 shares at an average $497.36 ($344,173)
- 144 Insider Sale of Securities
- 4 Open-market sale Director sold 2,238 shares at $490.77 ($1,098,343)
- 144 Insider Sale of Securities
- 4 Grant or award Chief Accounting Officer acquired 2,398 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 280 shares at $551.24 ($154,348)
- 4 Planned sale Director sold 24,520 shares at an average $522.39 ($12,808,957)
Page 4 of 62 · 1,224 filings